230 related articles for article (PubMed ID: 18718537)
1. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Vucković MG; Wood RI; Holschneider DP; Abernathy A; Togasaki DM; Smith A; Petzinger GM; Jakowec MW
Neurobiol Dis; 2008 Nov; 32(2):319-27. PubMed ID: 18718537
[TBL] [Abstract][Full Text] [Related]
2. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
Fisher BE; Petzinger GM; Nixon K; Hogg E; Bremmer S; Meshul CK; Jakowec MW
J Neurosci Res; 2004 Aug; 77(3):378-90. PubMed ID: 15248294
[TBL] [Abstract][Full Text] [Related]
3. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
Petzinger GM; Walsh JP; Akopian G; Hogg E; Abernathy A; Arevalo P; Turnquist P; Vucković M; Fisher BE; Togasaki DM; Jakowec MW
J Neurosci; 2007 May; 27(20):5291-300. PubMed ID: 17507552
[TBL] [Abstract][Full Text] [Related]
4. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
5. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
6. Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.
Gorton LM; Vuckovic MG; Vertelkina N; Petzinger GM; Jakowec MW; Wood RI
Behav Brain Res; 2010 Dec; 213(2):253-62. PubMed ID: 20472000
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
8. MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
Maiti P; Gregg LC; McDonald MP
Behav Brain Res; 2016 Feb; 298(Pt B):192-201. PubMed ID: 26393431
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Chen Y; Ni YY; Liu J; Lu JW; Wang F; Wu XL; Gu MM; Lu ZY; Wang ZG; Ren ZH
BMC Neurosci; 2013 Jul; 14():76. PubMed ID: 23902361
[TBL] [Abstract][Full Text] [Related]
10. Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.
Monaghan MM; Leddy L; Sung ML; Albinson K; Kubek K; Pangalos MN; Reinhart PH; Zaleska MM; Comery TA
Neurodegener Dis; 2010; 7(1-3):153-9. PubMed ID: 20197696
[TBL] [Abstract][Full Text] [Related]
11. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
12. Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Saitoh K; Abe K; Chiba T; Katagiri N; Saitoh T; Horiguchi Y; Nojima H; Taguchi K
Pharmacol Rep; 2013; 65(5):1204-12. PubMed ID: 24399716
[TBL] [Abstract][Full Text] [Related]
13. Influences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.
Janakiraman U; Manivasagam T; Thenmozhi AJ; Essa MM; Barathidasan R; SaravanaBabu C; Guillemin GJ; Khan MA
PLoS One; 2016; 11(1):e0146671. PubMed ID: 26765842
[TBL] [Abstract][Full Text] [Related]
14. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
15. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
16. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
VanLeeuwen JE; Petzinger GM; Walsh JP; Akopian GK; Vuckovic M; Jakowec MW
J Neurosci Res; 2010 Feb; 88(3):650-68. PubMed ID: 19746427
[TBL] [Abstract][Full Text] [Related]
17. Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Schumm S; Sebban C; Cohen-Salmon C; Callebert J; Launay JM; Golmard JL; Boussicault L; Petropoulos I; Hild A; Rousselet E; Prigent A; Friguet B; Mariani J; Hirsch EC
J Neurochem; 2012 Sep; 122(5):1032-46. PubMed ID: 22708926
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of Danshensu in Parkinson's disease mouse model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Han B; Che X; Zhao Y; Li C; He J; Lu Y; Wang Z; Wang T
Behav Pharmacol; 2019 Feb; 30(1):36-44. PubMed ID: 29847337
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
